Model Number 8637-20 |
Device Problems
Electromagnetic Interference (1194); Application Program Problem (2880)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 05/08/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider via manufacture representative regarding a patient receiving unknown drug via an implanted infusion pump.
It was reported the patient's pump did not recover after waiting 2 hours after the mri.
The caller stated the patient had since gone home and the office was closed.
Tech services recommended having the patient follow-up with the physician on monday.
It was noted the pump was at minimum rate mode.
No symptoms were reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received via pump session reports.
Review of the reports determined that the motor stall event no longer appeared in the logs because the pump had been updated multiple times.
The logs, by design, have a 30 entry capacity so the motor stall entry had dropped off as would be expected.
There was no issue with regards to the logs.
No further complications were reported/anticipated.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received via the pump logs.
The pump logs dated (b)(6) 2020 showed a motor stall occurred on (b)(6) 2020 at 12:08 pm.
The pump logs dated (b)(6) 2020 showed the pump motor stall recovery on (b)(6) 2020 at 3:26 am.
The last entry showing on the logs was dated (b)(6) 2020 at 1:39 pm which was after the stall that occurred at 12:08 pm.
The pump was delivering fentanyl (8,000 mcg/ml at 50 mcg/day), hydromorphone (6 mg/ml at 0.
0375 mg/day) and bupivacaine (15 mg/ml at 0.
094 mg/day) at the time of the event.
No further complications have been reported as a result of this event.
|
|
Search Alerts/Recalls
|